For over 25 years, Hans has been supporting the clinical development of novel therapies across various therapeutic areas, but in particular, cardiovascular and metabolic indications. His experience covers the full range of clinical development from first-in man until global phase III cardiovascular outcomes studies.
Hans has served as the Global Head of Cardiovascular and Metabolics at QuintilesIMS as well as Global Head of Regulatory and Start-up. He understands the challenges that our Biopharma partners face and is keen to ensure that Julius Clinical is truly invested in the success of our customers. He understands that the key to success often lies in the support we provide to our investigators to enable them to drive patient recruitment and collect high quality data.
Hans has a degree in Exercise Physiology and Functional Anatomy from the Free University Amsterdam, the Netherlands, and obtained part of his academic education at the Deptartment of Exercise Sciences at the University of Florida.